Prevents and repairs actinic injuries.

• Prevention and supportive protective treatment of actinic keratosis and other forms of non-melanoma skin cancer. Reduces and improves subclinical skin cancer associated with actinic keratosis or other forms of non-melanoma skin cancer.
• Actinic keratosis and other forms of non-melanoma skin cancer are diseases caused by chronic exposure to sunlight. If you have suffered from AK and NMSC, direct sun exposure should be avoided. Its use is not recommended for children, pregnant women and while breastfeeding. Avoid contact with eyes and mucous membranes. In case of a possible adverse reaction to any of the ingredients, stop treatment and consult a doctor. Keep out of the sight and reach of children. Shake the container before using. Apply only to clean, intact skin. Daily and continuous use is essential to prevent and treat AK and NMSC in a supportive way. In patients undergoing pharmacological or surgical treatment for AK or NMSC, start treatment with Eryfotona® AK-CPNM after the lesions have healed.
• Isdin SA
  Provençals 33, 08019, Barcelona (Espanha)
  www.isdin.com

Apply Eryfotona® AK-NMSC Fluid SPF100+ generously over the entire affected area and other areas at risk of chronic sun exposure, such as face, forehead, ears, décolleté, scalp and back of hands. Repeat the process twice a day: in the morning and at noon.

Daily use. Photolyase is activated with visible light. In case of direct exposure to the sun, reapply the product every two hours.

Reduces and improves the field of cancerization associated with actinic keratosis (AK) and non-melanoma skin cancer (NMSC). Creates a protective film on the skin, which prevents the appearance of new lesions and promotes the repair of existing lesions.

Repairsomes® (UVB-UVA filter complex + plankton extract), bisabolol, tocopheryl acetate, panthenol, excipients qb.

Isdin SA
Provençals 33, 08019, Barcelona (Espanha)
www.isdin.com